Suppr超能文献

哌拉西林/他唑巴坦诱导的免疫介导性贫血和血小板减少症。

Piperacillin/Tazobactam Induced Immune-Mediated Anaemia and Thrombocytopenia.

作者信息

Fritz Agnes-Sophie, Trendelenburg Marten, Mutke Markus

机构信息

Department of Internal Medicine, University Hospital of Basel, Basel, Switzerland.

出版信息

Eur J Case Rep Intern Med. 2025 Aug 18;12(9):005460. doi: 10.12890/2025_005460. eCollection 2025.

Abstract

UNLABELLED

Piperacillin/tazobactam (PTZ) is known to cause cytopenia but case reports on PTZ causing combined haemolytic anaemia and thrombocytopenia are scarce. We report on a 56-year-old male who developed severe, immune-mediated thrombocytopenia and anaemia during two treatment episodes with PTZ. After the first exposure, his blood count rapidly returned to normal after discontinuation of PTZ. One year later, in the context of an unintentional re-challenge with PTZ, the level of red blood cells and platelets dropped again causing acute haemolytic anaemia and immune thrombocytopenia. Recovery was delayed after discontinuation of PTZ. PTZ should be considered as a potential cause of immune-mediated bicytopenia.

LEARNING POINTS

Piperacillin/tazobactam can induce immune-mediated haemolytic anaemia and thrombocytopenia.Patients with underlying alteration of the immune system might be at higher risk for bicytopenia.

摘要

未标注

已知哌拉西林/他唑巴坦(PTZ)可导致血细胞减少,但关于PTZ引起溶血性贫血和血小板减少合并症的病例报告很少。我们报告了一名56岁男性,他在两次接受PTZ治疗期间出现了严重的、免疫介导的血小板减少和贫血。首次接触后,停用PTZ后他的血细胞计数迅速恢复正常。一年后,在无意中再次使用PTZ的情况下,红细胞和血小板水平再次下降,导致急性溶血性贫血和免疫性血小板减少。停用PTZ后恢复延迟。PTZ应被视为免疫介导的双血细胞减少的潜在原因。

学习要点

哌拉西林/他唑巴坦可诱发免疫介导的溶血性贫血和血小板减少。免疫系统存在潜在改变的患者可能发生双血细胞减少的风险更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e9/12416790/09d9f739963f/5460_Fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验